CVS Health Corporation $CVS Shares Bought by Aviva PLC

Aviva PLC boosted its stake in shares of CVS Health Corporation (NYSE:CVS) by 19.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 943,440 shares of the pharmacy operator’s stock after buying an additional 151,885 shares during the quarter. Aviva PLC owned 0.07% of CVS Health worth $65,078,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in CVS. Jennison Associates LLC grew its stake in shares of CVS Health by 503.8% in the first quarter. Jennison Associates LLC now owns 1,896,341 shares of the pharmacy operator’s stock valued at $128,477,000 after buying an additional 1,582,257 shares in the last quarter. Cantor Fitzgerald Investment Advisors L.P. lifted its position in CVS Health by 1.6% during the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after acquiring an additional 6,615 shares in the last quarter. Cerity Partners LLC grew its position in CVS Health by 25.0% in the first quarter. Cerity Partners LLC now owns 648,266 shares of the pharmacy operator’s stock valued at $43,920,000 after acquiring an additional 129,535 shares in the last quarter. Brandywine Global Investment Management LLC raised its stake in shares of CVS Health by 20.1% during the first quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock valued at $231,808,000 after purchasing an additional 572,533 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ lifted its position in shares of CVS Health by 122.5% during the first quarter. Skandinaviska Enskilda Banken AB publ now owns 565,152 shares of the pharmacy operator’s stock worth $38,289,000 after purchasing an additional 311,098 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.22% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on CVS. Truist Financial reaffirmed a “buy” rating and set a $95.00 price target (up previously from $92.00) on shares of CVS Health in a research note on Thursday, October 30th. Mizuho raised their target price on CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Zacks Research cut CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Morgan Stanley raised their price objective on CVS Health from $82.00 to $89.00 and gave the company an “overweight” rating in a research note on Tuesday, October 14th. Finally, Bernstein Bank dropped their price objective on CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a report on Wednesday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $89.45.

CVS Health Trading Up 0.4%

NYSE:CVS opened at $79.00 on Friday. The company has a market cap of $100.29 billion, a PE ratio of 207.90, a P/E/G ratio of 0.87 and a beta of 0.60. The business’s 50 day moving average is $77.15 and its two-hundred day moving average is $69.45. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $85.15.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business’s revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio is currently 700.00%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.